- Home
- FORM vs CPRX Comparison
FORM vs CPRX Comparison
Compare FORM & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORM
- CPRX
- Stock Information
- Founded
- FORM 1993
- CPRX 2002
- Country
- FORM United States
- CPRX United States
- Employees
- FORM N/A
- CPRX N/A
- Industry
- FORM Semiconductors
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- FORM Technology
- CPRX Health Care
- Exchange
- FORM Nasdaq
- CPRX Nasdaq
- Market Cap
- FORM 2.7B
- CPRX 2.6B
- IPO Year
- FORM N/A
- CPRX 2006
- Fundamental
- Price
- FORM $29.16
- CPRX $21.08
- Analyst Decision
- FORM Buy
- CPRX Strong Buy
- Analyst Count
- FORM 8
- CPRX 5
- Target Price
- FORM $38.14
- CPRX $33.20
- AVG Volume (30 Days)
- FORM 1.1M
- CPRX 1.4M
- Earning Date
- FORM 07-30-2025
- CPRX 08-06-2025
- Dividend Yield
- FORM N/A
- CPRX N/A
- EPS Growth
- FORM N/A
- CPRX 183.96
- EPS
- FORM 0.57
- CPRX 1.65
- Revenue
- FORM $764,554,000.00
- CPRX $558,499,000.00
- Revenue This Year
- FORM $2.18
- CPRX $16.37
- Revenue Next Year
- FORM $7.14
- CPRX $8.80
- P/E Ratio
- FORM $51.27
- CPRX $12.78
- Revenue Growth
- FORM 8.30
- CPRX 28.55
- 52 Week Low
- FORM $22.58
- CPRX $19.00
- 52 Week High
- FORM $51.68
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- FORM 43.28
- CPRX 52.80
- Support Level
- FORM $27.00
- CPRX $19.82
- Resistance Level
- FORM $30.62
- CPRX $20.80
- Average True Range (ATR)
- FORM 1.14
- CPRX 0.71
- MACD
- FORM 0.04
- CPRX 0.10
- Stochastic Oscillator
- FORM 59.67
- CPRX 57.10
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).